Tissue coating for preventing undesired tissue-to-tissue adhesions
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-009/00
A61K-031/721
A61P-017/02
A61K-009/14
A61K-031/717
A61P-043/00
A61L-031/14
A61L-031/04
출원번호
US-0989843
(2009-06-01)
등록번호
US-8932622
(2015-01-13)
국제출원번호
PCT/US2009/045777
(2009-06-01)
§371/§102 date
20101027
(20101027)
국제공개번호
WO2009/148985
(2009-12-10)
발명자
/ 주소
Shuey, Steven W.
출원인 / 주소
Actamax Surgical Materials, LLC
대리인 / 주소
McCarter & English
인용정보
피인용 횟수 :
0인용 특허 :
32
초록▼
Disclosed herein are a kit and a method for forming a tissue coating that prevents undesired tissue-to-tissue adhesions resulting from trauma, surgery, infection, or other stimulus. The tissue coating is a hydrogel formed by reacting an aminocarboxymethyldextran containing primary amine groups with
Disclosed herein are a kit and a method for forming a tissue coating that prevents undesired tissue-to-tissue adhesions resulting from trauma, surgery, infection, or other stimulus. The tissue coating is a hydrogel formed by reacting an aminocarboxymethyldextran containing primary amine groups with an oxidized carboxymethylcellulose containing aldehyde groups.
대표청구항▼
1. A kit suitable for forming a tissue coating that is capable of preventing undesired tissue-to-tissue adhesions comprising: a) at least one carboxymethyldextran that has been derivatized to provide at least one aminocarboxymethyldextran that contains primary amine groups wherein each said primary
1. A kit suitable for forming a tissue coating that is capable of preventing undesired tissue-to-tissue adhesions comprising: a) at least one carboxymethyldextran that has been derivatized to provide at least one aminocarboxymethyldextran that contains primary amine groups wherein each said primary amine group is directly bound to a primary, secondary or tertiary carbon atom, said at least one carboxymethyldextran having a weight-average molecular weight of about 1,000 to about 1,000,000 Daltons, and a degree of carboxymethylation of about 0.1 to about 2.5, said at least one aminocarboxymethyldextran having a primary amine substitution level of about 10% to about 150%; andb) at least one carboxymethylcellulose that has been oxidized to provide at least one oxidized carboxymethylcellulose containing aldehyde groups, said at least one oxidized carboxymethylcellulose having a weight-average molecular weight of about 5,000 to about 100,000 Daltons, and an equivalent weight per aldehyde group of about 125 to about 750 Daltons. 2. The kit according to claim 1 wherein the degree of carboxymethylation of the carboxymethyldextran is about 0.9 to about 2.1. 3. The kit according to claim 1 wherein the weight-average molecular weight of the carboxymethyldextran is about 10,000 to about 60,000 Daltons. 4. The kit according to claim 1 wherein the primary amine substitution level of the aminocarboxymethyldextran is about 10% to about 75%. 5. The kit according to claim 1 wherein the weight-average molecular weight of the oxidized carboxymethylcellulose is about 10,000 to about 30,000 Daltons. 6. The kit according to claim 1 wherein the equivalent weight per aldehyde group of the oxidized carboxymethylcellulose is about 180 to about 495 Daltons. 7. The kit according to claim 1 wherein the aminocarboxymethyldextran is contained in a first aqueous solution or dispersion and the oxidized carboxymethylcellulose is contained in a second aqueous solution or dispersion. 8. The kit according to claim 7 wherein the first aqueous solution or dispersion contains the aminocarboxymethyldextran at a concentration of about 5% to about 50% by weight relative to the total weight of the solution or dispersion. 9. The kit according to claim 7 wherein the second aqueous solution or dispersion contains the oxidized carboxymethylcellulose at a concentration of about 5% to about 50% by weight relative to the total weight of the solution or dispersion. 10. The kit according to claim 7 wherein at least one of the first aqueous solution or dispersion or the second aqueous solution or dispersion further comprises at least one additive selected from the group consisting of pH modifiers, viscosity modifiers, antimicrobials, colorants, healing promoters, surfactants, pharmaceutical drugs and therapeutic agents. 11. The kit according to claim 1 wherein the aminocarboxymethyldextran and the oxidized carboxymethylcellulose are in the form of finely divided powders. 12. A dried hydrogel formed by a process comprising the steps of: a) reacting in a solvent (i) at least one carboxymethyldextran that has been derivatized to provide at least one aminocarboxymethyldextran that contains primary amine groups wherein said primary amine group is directly bound to a primary, secondary or tertiary carbon atom, said at least one carboxymethyldextran having a weight-average molecular weight of about 1,000 to about 1,000,000 Daltons, and a degree of carboxymethylation of about 0.1 to about 2.5, said at least one aminocarboxymethyldextran having a primary amine substitution level of about 10% to about 150%; with (ii) at least one carboxymethylcellulose that has been oxidized to provide at least one oxidized carboxymethylcellulose containing aldehyde groups, said at least one oxidized carboxymethylcellulose having a weight-average molecular weight of about 5,000 to about 100,000 Daltons, and an equivalent weight per aldehyde group of about 125 to about 750 Daltons, to form a hydrogel; andb) treating said hydrogel to remove at least a portion of said solvent to form the dried hydrogel. 13. The dried hydrogel according to claim 12 wherein said dried hydrogel is in the form of a film. 14. The dried hydrogel according to claim 12 wherein said dried hydrogel is in the form of finely divided particles. 15. A method for forming a tissue coating that is capable of preventing undesired tissue-to-tissue adhesions comprising: applying to an anatomical site on tissue of a living organism:a) at least one carboxymethyldextran that has been derivatized to provide at least one aminocarboxymethyldextran that contains primary amine groups wherein said primary amine group is directly bound to a primary, secondary or tertiary carbon atom, said at least one carboxymethyldextran having a weight-average molecular weight of about 1,000 to about 1,000,000 Daltons, and a degree of carboxymethylation of about 0.1 to about 2.5, said at least one aminocarboxymethyldextran having a primary amine substitution level of about 10% to about 150%; followed byb) at least one carboxymethylcellulose that has been oxidized to provide at least one oxidized carboxymethylcellulose containing aldehyde groups, said at least one oxidized carboxymethylcellulose having a weight-average molecular weight of about 5,000 to about 100,000 Daltons, and an equivalent weight per aldehyde group of about 125 to about 750 Daltons;or applying (b) followed by (a) and mixing (a) and (b) on the site;orpremixing (a) and (b) and applying the resulting mixture to the site.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (32)
Tardy Michel,FRX ; Volckmann Herve,FRX ; Tiollier Jerome,FRX ; Gravagna Philippe,FRX ; Tayot Jean-Louis,FRX, Adhesive composition with macromolecular polyaldehyde base and method for cross-linking collagen.
Schaulin Rudolf (Riehen CHX) Lauk Urs (Zurich CHX), Azo dyes containing triazine middle components and a 1,4-phenylene-2,5-disubstituted coupling component.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Biologically inert, biocompatible-polymer conjugates.
Schwartz Herbert E. ; Blackmore John M., Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use i.
Schwartz Herbert E. ; Blackmore John M., Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Collagen-polymer conjugates.
Balazs Endre A. (Ft. Lee NJ) Leshchiner Adolf (Fairview NJ) Larsen Nancy E. (Ridgefield Park NJ), Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same.
Aeschlimann, Daniel; Bulpitt, Paul, Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same.
de Belder Anthony N. (Uppsala SEX) Mlson Thomas (Uppsala SEX), Method of preventing adhesion between body tissues, means for preventing such adhesion, and process for producing said m.
Jiang Ying (North Haven CT) Gruskin Elliott A. (Killingworth CT), Modified synthetic cross-linked amino acid polymers and medical devices formed therefrom.
Kuo Jing-Wen (Stoneham MA) Swann David A. (Lexington MA) Prestwich Glenn D. (Harbor NY), Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.